New technologies in interventional cardiology further enhance the company’s comprehensive portfolio of cardiology solutions across the full continuum of care – including the next generation of.
The Cleveland company's new CEO is Gulam Khan, a veteran of Northeast Ohio's medical technology industry who previously was CEO at Mentor-based US Endoscopy and a senior VP at STERIS Corp.